International Journal of Clinical and Experimental Medicine Research

ISSN Print: 2575-7989 Downloads: 113211 Total View: 1777036
Frequency: quarterly ISSN Online: 2575-7970 CODEN: IJCEMH
Email: ijcemr@hillpublisher.com
Article http://dx.doi.org/10.26855/ijcemr.2023.01.010

Sources and Accuracy of Information for Patients with Hepatitis C

E. Whitney Pollio1,*, Omar T. Sims2,3,4,5, Edward Randle6, Barry A. Hong7, Carol S. North8,9, David E. Pollio10

1College of Nursing, University of South Florida, Tampa, FL, USA.

2Department of Social Work, College of Arts and Sciences, University of Alabama at Birmingham, Birmingham, AL, USA. 

3Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.

4Center for AIDS Research, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

5Integrative Center for Healthy Aging, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

6Department of Social Work, College of Health Sciences and Human Services, Tarleton State University, Stephenville, TX, USA.

7Department of Psychiatry, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

8The Altshuler Center for Education & Research Metrocare Services, Metrocare Services, Dallas, TX, USA.

9Department of Psychiatry, School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

10Private Practice, Huntsville, AL, USA.

*Corresponding author: E. Whitney Pollio

Published: February 6,2023

Abstract

Favorable outcomes for patients with HCV depend on patients receiving accurate information about HCV and treatments. Effective patient communication consists of providers transmitting clear information and patients receiving and interpreting information accurately. Most patient communication research has focused on the former. The purpose of this study is to identify sources of patient information about HCV and treatment and examine accuracy. Data from 9 focus groups (N=48) were collected from patients recruited from large metropolitan public clinics and hospitals. Passages related to HCV (n=43) and treatment (n=50) were identified and coded by source and accuracy. Most (63%) information on HCV came from healthcare providers. In contrast, only 28% of treatment information came from providers. Accuracy of information received was 71%-89%. It is concerning that a substantial minority of disease process information and a majority of treatment information came from non-providers. It is also problematic that about ¼ of information was inaccurate. Focusing on communications from providers to clients to improve disease outcomes is overly simplistic.

References

[1] Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R., & Saab, S. (2011). Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International : Official Journal of the International Association for the Study of the Liver, 31(8), 1090-1101. https://doi.org/10.1111/j.1478-3231.2011.02494.x.

[2] Anderson, E. S., Galbraith, J. W., Deering, L. J., Pfeil, S. K., Todorovic, T., Rodgers, J. B., Forsythe, J. M., Franco, R., Wang, H., Wang, N. E., & White, D. A. E. (2017). Continuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department Setting. Clinical Infectious Diseases, 64(11), 1540-1546. https://doi.org/10.1093/cid/cix163.

[3] Allison, W. E., Chiang, W., Rubin, A., Oshva, L., & Carmody, E. (2016). Knowledge about Hepatitis C Virus Infection and Acceptability of Testing in the 1945–1965 Birth Cohort (Baby Boomers) Presenting to a Large Urban Emergency Department: A Pilot Study. The Journal of Emergency Medicine, 50(6), 825-831.e2. https://doi.org/10.1016/j.jemermed.2016.02.001.

[4] Galbraith, J. W., Franco, R. A., Donnelly, J. P., Rodgers, J. B., Morgan, J. M., Viles, A. F., Overton, E. T., Saag, M. S., & Wang, H. E. (2015). Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology, 61(3), 776-782. https://doi.org/10.1002/hep.27410.

[5] Golabi, P., Jeffers, T., Younoszai, Z., Otgonsuren, M., Sayiner, M., Mishra, A., Venkatesan, C., & Younossi, Z. M. (2017). Independent predictors of mortality and resource utilization in viral hepatitis related hepatocellular carcinoma. Annals of Hepatology, 16(4), 555–564. https://doi.org/10.5604/01.3001.0010.0290.

[6] Jafri, S.-M., & Gordon, S. C. (2018). Epidemiology of Hepatitis C. Clinical Liver Disease, 12(5), 140–142. https://doi.org/10. 1002/cld.783.

[7] Jost, J. J., Tempalski, B., Vera, T., Akiyama, M. J., Mangalonzo, A. P., & Litwin, A. H. (2019). Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs. International Journal of Environmental Research and Public Health, 16(11), 1958. https://doi.org/10.3390/ijerph16111958.

[8] Koman, D. (2018). Increasing Hepatitis C Virus Knowledge Through an Evidence-Based Educational Intervention. Gastroenterology Nursing : The Official Journal of the Society of Gastroenterology Nurses and Associates, 41(2), 95–102. https://doi.org/10.1097/SGA.0000000000000310.

[9] Lingala, S., & Ghany, M. G. (2015). NATURAL HISTORY OF HEPATITIS C. Gastroenterology Clinics of North America, 44(4), 717. https://doi.org/10.1016/J.GTC.2015.07.003.

[10] North, C. S., Devereaux, R., Pollio, D. E., Hong, B. A., & Jain, M. K. (2014). Patient perspectives on hepatitis C and its treatment. European Journal of Gastroenterology & Hepatology, 26(1), 74-81. https://doi.org/10.1097/MEG.0b013e32836382b5.

[11] North, C. S., Hong, B. A., Adewuyi, S. A., Pollio, D. E., Jain, M. K., Devereaux, R., Quartey, N. A., Ashitey, S., Lee, W. M., & Lisker-Melman, M. (2013). Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations. General Hospital Psychiatry, 35(2), 122–128. https://doi.org/10.1016/j.genhosppsych.2012.11.002.

[12] Scotto, R., Buonomo, A. R., Moriello, N. S., Maraolo, A. E., Zappulo, E., Pinchera, B., Gentile, I., & Borgia, G. (2019). Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection. Reviews on Recent Clinical Trials, 14(3), 173–182. https://doi.org/10.2174/1574887114666190306154650.

[13] Shehata, N., Austin, T., Ha, S., & Timmerman, K. (2018). Barriers to and facilitators of hepatitis C virus screening and testing: A scoping review. Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada, 44(7–8), 166–172. http://www.ncbi.nlm.nih.gov/pubmed/31011297.

[14] Taylor, L. E., Swan, T., & Mayer, K. H. (2012). HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 55 Suppl 1(Suppl 1), S33-42. https://doi.org/10.1093/cid/cis367.

[15] Zeremski, M., Zavala, R., Dimova, R. B., Chen, Y., Kritz, S., Sylvester, C., Brown, L. S., & Talal, A. H. (2016). Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Journal of Addiction Medicine, 10(2), 104–109. https://doi.org/10.1097/ADM.0000000000000196.

How to cite this paper

Sources and Accuracy of Information for Patients with Hepatitis C

How to cite this paper: E. Whitney Pollio, Omar T. Sims, Edward Randle, Barry A. Hong, Carol S. North, David E. Pollio. (2023) Sources and Accuracy of Information for Patients with Hepatitis C. International Journal of Clinical and Experimental Medicine Research7(1), 56-60.

DOI: http://dx.doi.org/10.26855/ijcemr.2023.01.010